Akston Biosciences
Todd Zion has over 15 years of experience in the biotech industry. Todd is currently the President & CEO and Chairman of the Board at Akston Biosciences. Previously, they were the Director at Devereux School (MA), Consultant at 454C, LLC, and Co-founder, President and CEO at SmartCells, Inc.
Todd Zion has a Bachelor of Science degree in Biochemistry from the University of California, Davis.
Todd Zion received their Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology and their B.S. in Chemical Engineering from Cornell University.
Some individuals on their team include Thillainaygam Sathiyaseelan - VP, Quality & Regulatory Affairs, James Herriman - VP, Operations, and Thomas Lancaster - VP, Manufacturing & Product Research & Development, Director.
This person is not in any teams
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.